Jump to:
A |
D |
H |
S |
YNumber of items at this level: 5.
A
Al-Kubaisi, K.A., De Ste Croix, M., Vinson, Don ORCID: https://orcid.org/0000-0003-3116-4828, Baig, M.R., El Din Hassan, M.N., Sharif, S.I. and Abduelkarem, A.R.
(2017)
Appropriateness Assessment and Identifying the Risk Factors of Oral Non-prescription Drugs Use Among University Students in the United Arab Emirates.
Academia Journal of Educational Research, 5 (10).
pp. 363-369.
ISSN 2315-7704
D
Di Miceli, Mathieu ORCID: https://orcid.org/0000-0003-3713-0370, Derf, A. and Gronier, B.
(2022)
Consequences of Acute or Chronic Methylphenidate Exposure Using Ex Vivo Neurochemistry and In Vivo Electrophysiology in the Prefrontal Cortex and Striatum of Rats.
International Journal of Molecular Sciences, 23 (15).
p. 8588.
ISSN 1422-0067
H
Harris, Matthew ORCID: https://orcid.org/0000-0002-4895-8360 and Kaur, Gurpreet
(2022)
Analgesic medicines not administered to those with dementia in residential settings despite awareness of undertreatment of and susceptibility to severe pain.
Evidence-Based Nursing.
ISSN Print: 1367-6539 Online: 1468-9618
S
Sud, D., Laughton, E., McAskill, R., Bradley, Eleanor ORCID: https://orcid.org/0000-0001-5877-2298 and Maidment, I.
(2021)
The role of pharmacy in the management of cardiometabolic risk, metabolic syndrome and related diseases in severe mental illness: a mixed methods systematic literature review.
Systematic Reviews, 10 (92).
ISSN Electronic: 2046-4053
Y
Younas, M., Holmes, N., Bradley, Eleanor ORCID: https://orcid.org/0000-0001-5877-2298, Sud, D. and Maidment, I.
(2016)
Mental Health Pharmacists Views on Shared Decision-Making for Antipsychotics in Serious Mental Illness.
International Journal of Clinical Pharmacy.
pp. 1-9.
ISSN Print 2210-7703 Online 2210-7711
This list was generated on Sat Dec 14 10:15:54 2024 UTC.